Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BM-MNC and UC-MSC in Type 2 Diabetes Mellitus
NCT03943940Phase 2Unknown
- Sponsor
- Van Hanh General Hospital
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow mononuclear cells, wharton's jelly mesenchymal stromal cells in type 2 diabetes mellitus (T2DM), sponsored by Van Hanh General Hospital. Status: unknown.
02
Drugs
bone marrow mononuclear cellswharton's jelly mesenchymal stromal cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03943940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03943940.